Article info

Download PDFPDF

Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: ‘More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia’ by Ferraccioli
Free

Authors

  • Emanuel Della-Torre Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Corrado Campochiaro Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Giulio Cavalli Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Giacomo De Luca Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Fabio Ciceri Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy Hematology and Bone Marrow Transplant Unit, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Alberto Zangrillo Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy Department of Anesthesia and Intensive Care, San Raffele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  • Lorenzo Dagna Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), San Raffaele Scientific Institute, Milan, Italy Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Emanuel Della-Torre, Università Vita-Salute San Raffaele, San Raffaele Scientific Institute, Milan 20132, Italy; dellatorre.emanuel{at}hsr.it
View Full Text

Citation

Della-Torre E, Campochiaro C, Cavalli G, et al
Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: ‘More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia’ by Ferraccioli

Publication history

  • Received July 23, 2020
  • Revised July 26, 2020
  • Accepted July 27, 2020
  • First published July 31, 2020.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.